Elmedical

Elmedical Overview

Elmedical provides an office-based system composed of a console and catheters designed for minimally invasive, non-ablative, high-temperature treatments (hyperthermia) for unmet urological diseases such as bladder cancer and prostatitis. Bladder wall thermochemotherapy (BWT) provides chemotherapy instillation at a uniform and precise 44 to 44.5 degrees Celsius over the entire bladder lumen. To secure drug stability and achieve an exact and uniform temperature, BWT uses a carefully heated mitomycin C solution at a predetermined hyperthermia temperature that circulates through the bladder in a high flow, with the entire contents of the bladder replaced four to five times per minute. In BWT, the heat content of the circulating solution exceeds what is required to transfer to the thermally conductive bladder wall. DuoThermia for chronic prostatitis/chronic pelvic pain syndrome in males is the simultaneous hyperthermia treatment of the prostate and bladder administered by a heated balloon in the prostatic urethra and free circulation of a heated saline in the bladder. Approximately 8,500 BWT and DuoThermia procedures have been successfully performed, with good patient tolerance both during and after the procedures.

Latest News

Jan 1, 2016 · www.ncbi.nlm.nih.gov

growth-positive

Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study - PubMed

The article discusses the efficacy and safety of a new device called Unithermia, developed by Elmedical Ltd, for intravesical thermochemotherapy in non-grade 3 non-muscle-invasive bladder cancer (NMIBC) patients who have failed Bacillus Calmette-Guerin (BCG) treatment. The study shows that Unithermia has an interesting activity and safety profile in this selected subgroup of NMIBC patients, suggesting its potential as a second-line therapy. The article provides details of the study design, patient eligibility, treatment outcomes, and toxicity levels. The key theme of the article is the evaluation of Unithermia as a potential treatment option for non-grade 3 NMIBC patients who have failed BCG. The key issues discussed in the article are related to customers, as the study evaluates the impact of Unithermia on patient outcomes.

Customers

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

HaHarash St 29, Hod Hasharon, Israel

Photos & Videos

3 item(s)

Elmedical Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info